Main Street Research’s Elevance Health ELV Stock Holding History

Main Street Research’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-27,861	Closed	-$12.1M	–	108
2023 Q3	$12.1M	Sell	27,861 -31,018	-53%	-$14.1M	1.25%	34
2023 Q2	$26.2M	Sell	58,879 -1,311	-2%	-$605K	4.17%	6
2023 Q1	$27.7M	Buy	60,190 +742	+1%	+$353K	5.46%	6
2022 Q4	$30.5M	Buy	59,448 +1,587	+3%	+$806K	7.43%	5
2022 Q3	$26.3M	Buy	57,861 +1,106	+2%	+$529K	5.79%	7
2022 Q2	$27.4M	Sell	56,755 -1,813	-3%	-$897K	7.18%	5
2022 Q1	$28.8M	Buy	58,568 +2,644	+5%	+$1.21M	2.7%	15
2021 Q4	$25.9M	Buy	+55,924	New	+$23.5M	2%	26
2018 Q3	–	Sell	-1,029	Closed	-$245K	–	112
2018 Q2	$245K	Sell	1,029 -372	-27%	-$86.1K	0.04%	100
2018 Q1	$308K	Buy	+1,401	New	+$329K	0.05%	86

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Main Street Research's ELV Position: Q4 2023 in Review

Main Street Research sold out of Elevance Health (ELV) in Q4 2023, closing a stake of 27,861 shares — an estimated $12.1M sold.

Main Street Research first reported a position in ELV in Q1 2018 and held it in 10 quarters. The position peaked at $30.5M in Q4 2022. 1,656 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

Main Street Research reported no remaining Elevance Health position as of Q4 2023 after selling out during the quarter.
Main Street Research sold 27,861 Elevance Health shares in Q4 2023, an estimated $12.1M.
Main Street Research first reported a position in Elevance Health in Q1 2018 and held it in 10 quarters.
Main Street Research's Elevance Health position peaked at $30.5M in Q4 2022.
1,656 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Main Street Research's 13F filing for Q4 2023, filed 30 Jan 2024.